Trial ID or NCT#

NCT01774097

Status

RECRUITING

Purpose

The purpose of this study is to find out if aldehyde dehydrogenase bright (ALDHbr) cells taken from a patient's bone marrow can be placed safely, via intramuscular injections, into their affected calf and lower thigh muscles and improve blood flow and/or peak walking time in patients experiencing pain associated with blocked blood vessels in the leg.

Official Title

Clinical and MR Imaging Assessments in Patients With Intermittent Claudication Following Injection of Bone Marrow Derived ALDH Bright Cells

Eligibility Criteria

Ages Eligible for Study: Older than 40 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Phillip C. Yang, MD
Cardiologist
Associate Professor of Medicine (Cardiovascular Medicine) at the Stanford University Medical Center
Nicholas Leeper
Cardiologist, Vascular medicine specialist
Associate Professor of Surgery (Vascular Surgery) and Medicine (Cardiovascular Medicine) at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Fouzia Khan
(650) 736-1410